The value of placental pathology in studies of spontaneous prematurity

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 2, 1996, Pages 89-98

  Salafia, Carolyn M ^a   Mill, John F ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CHORIOAMNIONITIS; FETOPLACENTAL UNIT; HUMAN; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; REVIEW; UTERUS CONTRACTION;

EID: 0029942657     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199604000-00002     Document Type: Review

References (65)

1. Nordenvall M, Sandstedt B: Chorioamnionitis in relation to gestational outcome in a Swedish population. Eur J Obstet Gynecol Reprod Biol 1990, 36:59-67.
2. Mueller-Heubach E, Rubinstein DN, Schwarz SS: Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990, 75:622-626.
3. Morizaki J: Experimental and clinical study on chorioamnionitis as a cause of preterm labor [in Japanese]. Nippon Sanka Fujinka Gakkai Zasshi 1992, 44:41-48.
4. Greig PC, Ernest JM, Teot L, Erikson M, Talley R: Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amnitoic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 1993, 169:1035-1044.
5. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I: Premature labor and intra-amniotic infection: clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995, 22:281-342. A comprehensive review focusing on acute ascending infection from a major research group.
6. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM: The preterm labor syndrome. Ann NY Acad Sci 1994, 734:414-429. A general review attempting to provide a broad clinical basis for understanding diverse causes of PTL.
7. Salafia CM, Minior VK, Rosenkrantz TS, Pezzullo JC, Popek EJ, Cusick W, Vintzileos AM: Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation. Am J Perinatol 1995, 12:427-434. A large data set of extremely preterm births that shows the significant role of histologic features in identifying precursors to neonatal sequelae of prematurity.
8. Verma U, Tejani N, Klein S, Jeanty W, Dweck H, Zoma W, Comacho G, Leikin E: Obstetrical antecendents of neonatal periventricular leucomalacia (PVL) [Abstract]. Am J Obstet Gynecol 1994, 170:264.
9. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, Syn HC: Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995, 172:960-970. A study correlating laboratory analysis, histopathology, and clinical outcome.
10. Stancombe BB, Walsh WF, Derdak S, Dixon P, Hensley D: Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin Infect Dis 1993, 17:154-157.
11. Payne NR, Steinberg SS, Ackerman P, Chrenka BA, Sane SM, Anderson KT, Fangman JJ: New prospective studies of the association of Ureaplasma urealyticum colonization and chronic lung disease. Clin Infect Dis 1993, 17:117-121.
12. Salafia CM, Vintzileos AM, Bantham KF, Vogel CA, Pezzullo J, Silberman L: Placental pathologic findings in preterm birth. Am J Obstet Gynecol 1991, 165:934-938.
13. Naeye RL: Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol 1989, 20:441-444.
14. Arias F, Rodriquez L, Rayne SC, Kraus FT: Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993, 168:585-591.
15. Tang MY: Pathologic analysis of preterm delivery placentas. Chin Med J [Engl] 1990, 103:856-861.
16. Suska P, Jakubovsky J, Polak S: Premature delivery and placenta. A morphological study. Czech Med 1990, 13:193-212.
17. Strigini FAL, Lencioni G, de Luca G, Lombardo M, Bianchi F, Genazzani AR: Uterine artery velocimetry and spontaneous preterm delivery. Obstet Gynecol 1995, 85:374-377. Clinical evaluation can detect abnormal uteroplacental vasculature in spontaneous prematurity.
18. Salafia CM, Ernst L, Pezzullo JP, Wolf W, Rosenkrantz TS, Vintzileos AM: The very low birth weight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995, 12:106-110. Using low birth weight rather than gestational age at delivery, the defined population suggests that timing and lesion burden differ between spontaneous and preeclampsia prematurity.
19. Redline RW, Pappin A: Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995, 26:80-85. This study shows that a diagnosis infrequently made by a nonspecialist can be antenatally detected by umbilical artery Doppler velocimetry.
20. Salafia CM, Lopez-Zeno JA, Sherer DM, Whittington SS, Minior VK, Vintzileos AM: Histologic evidence of old intrauterine bleeding is more frequent in prematurity. Am J Obstet Gynecol 1995, 173:1065-1070.
21. Sherer DM, Salafia CM, Minior VK, Sanders M, Ernst L, Vintzileos AM: Placental basal plate myometrial fibers: clinical correlations of abnormally deep trophoblast invasion. Obstet Gynecol 1996 (In press).
22. Salafia CM, Minior VK, López-Zeno JA, Whittington SS, Pezzullo JC, Vintzileos AM: Relationship between placental histologic features and umbilical cord blood gases in preterm gestations. Am J Obstet Gynecol 1995, 173:1058-1064.
23. Gould SJ: The real error of Cyril Burt: factor analysis and the reification of intelligence. In: The Mismeasure of Man. New York: WW Norton and Co; 1993:238.
24. Salafia CM, Pezzullo JC, López-Zeno JA, Simmens S, Minior VK, Vintzileos AM: Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol 1995, 173:1097-1105. A demonstration of the use of a novel analytic method (factor analysis) to recognize clinically significant patterns of placental pathology.
25. Salafia C, Lopez-Zeno J, Minior V, Pezzullo J, Ghidini A, Spong C, Ernst LM: 'Preeclamptic' uteroplacental pathology is associated with increased maternal mean blood pressure in spontaneous prematurity [Abstract]. Am J Obstet Gynecol 1996. 174:474.
26. Salafia CM, Pezzullo JC, Vintzileos AM, Minior VK, Romero R: Placental pathology of preterm labor and preterm membrane rupture < 32 weeks are qualitatively similar but quantitatively different [Abstract]. Am J Obstet Gynecol 1995, 172:419.
27. Salafia CM, Pezzullo JC, Vintzileos AM, Romero R: Placental histology in individual cases of spontaneous premature delivery is heterogeneous [Abstract]. Am J Obstet Gynecol 1995, 172:419.
28. Salafia CM, Silberman L: Chronic placental lesions in cases of preterm labor delivering at term [Abstract]. Am J Obstet Gynecol 1996. 174:363.
29. Robertson WB, Brosens I, Dixon G: Uteroplacental vascular pathology. Eur J Obstet Gynecol Reprod Biol 1975, 5:47-65.
30. Meekins JW, Pijnenborg R, Hanssens M, van Assche A, McFadyen IR: Immunohistochemical detection of lipoprotein (a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies. Placenta 1991, 15:511-524.
31. Starzyk K, Salafia CM, Vercruysse L, Lage JM, Pezzullo JC, Pijnenborg R: Quantitative vascular changes of the uteroplacental anatomy in placental bed biopsy define preeclampsia. [Abstract]. Am J Obstet Gynecol 1996. 174:369.
32. Wolf K, Rath M, Niendorf A, Beisiegel U, Dietel M: Morphological colocalization of apoprotein (a) and fibrin(ogen) in human coronary atheromas [Abstract]. Circulation 1989, 80:II-522.
33. Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, Lawn RM, Scanu AM.: Partial amnio acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987, 84:3224-3228.
34. Karádi I, Kostner GM, Gries A, Nimpf J, Romics L, Malle E: Lipoprotein (a) and plasminogen are immunochemically related. Biochim Biophys Acta 1988, 960:91-97.
35. Bowie EJW: Lipid-related clotting reactions of clinical significance. Arch Pathol Lab Med 1992, 116:1345-1349.
36. Loscalzo J, Fless GM, Scanu A: Lipoprotein (a) inhibits fibrin-dependent enhancement of tissue plasminogen activator activity [Abstract]. Blood 1988, 72:370.
37. Loscalzo J: The induction of cellular interactions in atherogenesis and their modulation. Biochem Soc Trans 1993, 21:656-659.
38. Harpel PC, Borth W: Fibrin, lipoprotein (a), plasmin interactions: a model linking thrombosis and atherogenesis. Ann NY Acad Sci 1992, 667:233-238.
39. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A: A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynecol 1994, 101:669-674.
40. Salafia CM, Starzyk K, Ossandon M, Vercruysse L, Parkash V, Lage J, Pijnenborg R: Lipoprotein (a) deposition in the uteroplacental bed distinguishes normal and preeclamptic pregnancies. [Abstract]. Am J Obstet Gynecol 1996, 174:363.
41. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med 1986, 314:488-500.
42. Andrew A, Bulmer JN, Morrison L, Wells M, Buckley CH: Subinvolution of the uteroplacental arteries: an immunohistochemical study. Int J Gynecol Pathol 1993, 12:28-33.
43. Salafia CM, Starzyk K, Lage J, Ossandon M, Vercruysse L, Parkash V, Spong CY, Pijnenborg R: Lipoprotein (a) in spiral arteries at term and after placental delivery: can involution-related processes begin before parturition? [Abstract]. Am J Obstet Gynecol 1996. 174:207.
44. Salafia CM, Starzyk KA, Ossandon M, Vercruysse L, Parkash V, Lage J, Pijnenborg R: Lipoprotein (a) in distal (basal plate) uteroplacental vessels: high level expression associated with non-hypertensive prematurity. [Abstract]. Am J Obstet Gynecol 1996. 174:362.
45. Takemura M, Kimura T, Nomura S, Makino Y, Inoue T, Kikuchi T, Kubota Y, Tokugawa Y, Nobunaga T, Kamiura S, et al.: Expression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturition. J Clin Invest 1994, 93:2319-2323.
46. Kubota Y, Kimura T, Takemura M, Inoue T, Kikuchi T, Ono M, Kanai T, Azuma C, Saji F, Tanizawa O: A novel method for detection of uterine oxytocin receptor in preparation for delivery using scraped endocervical cells. Horm Metab Res 1994, 26:442-443. A description of the first clinically relevant use of oxytocin receptor complementary DNA determinations.
47. Benedetto MT, De Cicco F, Rossiello F, Nicosia AL, Lupi NG, Dell'Acqua S: Oxytocin receptor in human fetal membranes at term ard during labor. J Steroid Biochem 1990, 35:205-208.
48. Fuchs AR, Fuchs F, Husslein P, Soloff MS: Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984, 150:734-741.
49. Chen DL, Chan WY, Manning M: Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats. J Reprod Fertil 1994, 102:337-343. A description and characterization of both types of oxytocin receptors.
50. Husslein PA, Fuchs AR, Fuchs F: Oxytocin and the initiation of human parturition. I. Prostaglandin release during induction of labor by oxytocin. Am J Obstet Gynecol 1981, 141:688-693.
51. Fuchs AR, Husslein P, Fuchs F: Oxytocin and the initiation of human parturition. II. Stimulation of prostaglandin production in human decidua by oxytocin. Am J Obstet Gynecol 1981, 141:694-698.
52. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H: Structure and expression of a human oxytocin receptor. Nature 1992, 356:526-529.
53. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T, Kubota Y, Ogita K, Fumitaka S: Structural organization of the human oxytocin receptor gene. J Biol Chem 1994, 269:32451-32456. The characterization of the human oxytocin receptor gene and its promoter.
54. Atke A, Sjoholm P, Olhansen C, Vilhardt H: Activation of inositol phosphates in the myometrium. Ann NY Acad Sci 1993, 689:473-474.
55. Berridge MJ: Inositol phosphate and diacylglycerol as second messengers. Biochem J 1984, 220:350-360.
56. Sugimoto Y, Hasumoto K, Namba T, Irie A, Katsuyama M, Negishi M, Kakizuka A, Narumiya S, Ichikawa A: Cloning and expression of a cDNA for mouse protaglandin F receptor. J Biol Chem 1994, 269:1356-1360.
57. Funk CD, Furci L, FitzGerald GA, Grygorczyk K, Rochette C, Bayne MA, Abramovitz M, Adam M, Metters KM: Cloning and expression of a cDNA for the human prostaglandin E receptor EP-1 subtype. J Biol Chem 1993, 268:26767-26772.
58. Briggs MR, Kadonaga JT, Bell SP, Tjian R: Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 1986, 234:47-52.
59. Poli V, Mancini FP, Cortese R: IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 1990, 63:643-653.
60. Akira S, Nishis Y, Inoue M, Wang X-J, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994, 77:63-71.
61. Lee W, Mitchell P, Tjian R: Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 1987, 49:741-752.
62. Orkin SH: Globin gene regulation and switching: circa 1990. Cell 1990, 63:665-672.
63. Williams T, Tjian R: Characterization of a dimerization motiff in AP-2 and its function in heterologous DNA-binding proteins. Science 1991, 251:1067-1071.
64. Howe KM, Reakes CFL, Watson RJ: Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. EMBO J 1990, 9:161-169.
65. Peale FV, Ludwig LB, Zain S, Hilf R, Bambara RA: Properties of a high-affinity DNA binding site for estrogen receptor. Proc Natl Acad Sci USA 1988, 85:1038-1042.